Amendment and Mail Process Complete

FLEXISTAT DRAWER

Qiagen GmbH

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 79367873 FILING DATE 03/02/2023
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # 1725418 INTL REG DATE 03/02/2023
TM ATTORNEY SETTLES LEWIS, SHAILA
L.O. ASSIGNED 114

PUB INFORMATION

RUN DATE 12/30/2023
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 12/29/2023
LITERAL MARK ELEMENT FLEXISTAT DRAWER

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A YES 66A YES

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT FLEXISTAT DRAWER
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Qiagen GmbH
ADDRESS Qiagen Str. 1
40724 Hilden
ENTITY 99-OTHER
CITIZENSHIP Germany

GOODS AND SERVICES

INTERNATIONAL CLASS 009
          DESCRIPTION TEXT Single-use cartridges for clinical laboratory use; single-use cartridges for clinical laboratory use containing nucleic acid extraction column and/or real time Polymerase Chain Reaction chambers
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Medical diagnostic apparatus and instruments for detecting tumors, cancer and genetic diseases, for DNA and RNA testing for medical purposes, for diagnostic testing body fluid, body tissue and organ samples, for diagnostic medical testing for cancer, for detecting and treating tumors and cancer, for detecting genetic predispositions, for detecting pathogens and disease biomarkers; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; analysers for medical use for detecting tumors, cancer and genetic diseases; medical diagnostic apparatus and instruments, namely DNA sequencers; analysers for medical diagnosis of tumors, cancer, genetic diseases, genetic predispositions, pathogens and disease biomarkers; testing instruments for medical diagnostic purposes for detecting tumors, cancer, genetic diseases, genetic predispositions, pathogens and disease biomarkers; apparatus for carrying-out diagnostic tests for medical purposes for detecting tumors, cancer, genetic diseases, genetic predispositions, pathogens and disease biomarkers; medical and clinical diagnosis apparatus and machines, namely, molecular and immunoassay analyzers for analyzing blood and bodily fluids

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 009 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DISCLAIMER W/PREDETER TXT "DRAWER"

SECTION 66A INTERNATIONAL REGISTRATION DATA

INTL REG # 1725418
INTL REG DATE 03/02/2023
PRIORITY CLMD YES
PRIOR CLMD DATE 11/14/2022
INTL STATUS 001-REQUEST FOR EXTENSION OF PROTECTION PROCESSED
INTL STATUS DATE 04/20/2023
AUTO PROTECTION DATE 10/20/2024
INTL RENEWAL DATE 03/02/2033
INTL REG DEATH DATE N/A
FIRST REFUSAL YES

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
12/29/2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 012
12/29/2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 011
12/29/2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 010
08/02/2023 RFNT P REFUSAL PROCESSED BY IB 009
07/10/2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB 008
07/10/2023 RFRR P REFUSAL PROCESSED BY MPU 007
06/02/2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW 006
06/01/2023 CNRT R NON-FINAL ACTION WRITTEN 005
05/26/2023 DOCK D ASSIGNED TO EXAMINER 004
04/25/2023 MAFR O APPLICATION FILING RECEIPT MAILED 003
04/21/2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED 002
04/20/2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY G MATHEW LOMBARD
CORRESPONDENCE ADDRESS G MATHEW LOMBARD
LOMBARD & GELIEBTER LLP
230 PARK AVE
4 FLOOR WEST
NEW YORK,NY 10169
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed